OR4K13
gene geneOn this page
Summary
OR4K13 (olfactory receptor family 4 subfamily K member 13, HGNC:15351) is a protein-coding gene on chromosome 14q11.2, encoding Olfactory receptor 4K13 (Q8NH42). Odorant receptor.
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome.
Source: NCBI Gene 390433 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 54 total
- MANE Select transcript:
NM_001004714
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:15351 |
| Approved symbol | OR4K13 |
| Name | olfactory receptor family 4 subfamily K member 13 |
| Location | 14q11.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000176253 |
| Ensembl biotype | protein_coding |
| Entrez | 390433 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000641664, ENST00000641904
RefSeq mRNA: 2 — MANE Select: NM_001004714
NM_001004714, NM_001386029
CCDS: CCDS32028
Canonical transcript exons
ENST00000641904 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003812365 | 20029399 | 20034981 |
| ENSE00003813304 | 20035938 | 20036038 |
Expression profiles
Bgee: expression breadth not_expressed, 0 present calls, max score 43.24.
Top tissues by expression
132 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| ventricular zone | UBERON:0003053 | 43.24 | gold quality |
| colonic epithelium | UBERON:0000397 | 41.17 | gold quality |
| sural nerve | UBERON:0015488 | 39.89 | gold quality |
| bone marrow cell | CL:0002092 | 39.88 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 38.01 | gold quality |
| ganglionic eminence | UBERON:0004023 | 37.13 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow | UBERON:0002371 | 35.76 | gold quality |
| monocyte | CL:0000576 | 35.49 | gold quality |
| leukocyte | CL:0000738 | 35.26 | gold quality |
| granulocyte | CL:0000094 | 34.44 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 34.16 | gold quality |
| liver | UBERON:0002107 | 33.81 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| primary visual cortex | UBERON:0002436 | 32.65 | gold quality |
| muscle tissue | UBERON:0002385 | 32.21 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| adrenal tissue | UBERON:0018303 | 31.77 | gold quality |
| urinary bladder | UBERON:0001255 | 31.16 | gold quality |
| fundus of stomach | UBERON:0001160 | 30.52 | gold quality |
| blood | UBERON:0000178 | 30.48 | gold quality |
| tonsil | UBERON:0002372 | 30.10 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.94 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| lymph node | UBERON:0000029 | 29.84 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 29.69 | gold quality |
| right lobe of liver | UBERON:0001114 | 29.61 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 29.42 | gold quality |
| pancreas | UBERON:0001264 | 28.92 | gold quality |
| body of pancreas | UBERON:0001150 | 28.51 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.92 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Paralogs (130): OR1I1 (ENSG00000094661), OR12D3 (ENSG00000112462), OR7A10 (ENSG00000127515), OR7C2 (ENSG00000127529), OR7C1 (ENSG00000127530), OR1E2 (ENSG00000127780), OR1J1 (ENSG00000136834), OR1L4 (ENSG00000136939), OR4D1 (ENSG00000141194), OR4K1 (ENSG00000155249), OR3A3 (ENSG00000159961), OR7G1 (ENSG00000161807), OR1Q1 (ENSG00000165202), OR1K1 (ENSG00000165204), OR4K2 (ENSG00000165762), OR4D6 (ENSG00000166884), OR1F1 (ENSG00000168124), OR4K14 (ENSG00000169484), OR4K15 (ENSG00000169488), OR7G3 (ENSG00000170920), OR7G2 (ENSG00000170923), OR1M1 (ENSG00000170929), OR4D5 (ENSG00000171014), OR1L6 (ENSG00000171459), OR1L3 (ENSG00000171481), OR1L8 (ENSG00000171496), OR1N2 (ENSG00000171501), OR1N1 (ENSG00000171505), OR2AT4 (ENSG00000171561), OR1A1 (ENSG00000172146), OR1A2 (ENSG00000172150), OR4C11 (ENSG00000172188), OR4X2 (ENSG00000172208), OR4D9 (ENSG00000172742), OR10K1 (ENSG00000173285), OR1L1 (ENSG00000173679), OR7D4 (ENSG00000174667), OR4S2 (ENSG00000174982), OR4B1 (ENSG00000175619), OR4D11 (ENSG00000176200)
Protein
Protein identifiers
Olfactory receptor 4K13 — Q8NH42 (reviewed: Q8NH42)
Alternative names: Olfactory receptor OR14-27
All UniProt accessions (2): A0A126GVS2, Q8NH42
UniProt curated annotations — full annotation on UniProt →
Function. Odorant receptor.
Subcellular location. Cell membrane.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (2): NP_001004714, NP_001372958 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000725 | Olfact_rcpt | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
| IPR050427 | Olfactory_Receptors | Family |
Pfam: PF13853
UniProt features (19 total): topological domain 8, transmembrane region 7, chain 1, glycosylation site 1, disulfide bond 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NH42-F1 | 83.88 | 0.45 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 97–189
Glycosylation sites (1): 5
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9752946 | Expression and translocation of olfactory receptors |
MSigDB gene sets: 17 (showing top):
GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, KEGG_OLFACTORY_TRANSDUCTION, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN, GOMF_OLFACTORY_RECEPTOR_ACTIVITY, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_SENSORY_PERCEPTION_OF_SMELL, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, REACTOME_OLFACTORY_SIGNALING_PATHWAY, REACTOME_SENSORY_PERCEPTION, GOBP_DETECTION_OF_CHEMICAL_STIMULUS, GOMF_MOLECULAR_TRANSDUCER_ACTIVITY
GO Biological Process (4): signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of smell (GO:0007608), detection of chemical stimulus involved in sensory perception of smell (GO:0050911)
GO Molecular Function (2): G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Olfactory Signaling Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transmembrane signaling receptor activity | 2 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of chemical stimulus | 1 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
88 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OR4K13 | CCDC91 | Q7Z6B0 | 477 |
| OR4K13 | INPP5B | P32019 | 391 |
| OR4K13 | AP1G1 | O43747 | 371 |
| OR4K13 | KCNC2 | Q96PR1 | 348 |
| OR4K13 | PIP4K2A | P48426 | 324 |
| OR4K13 | KCNQ5 | Q9NR82 | 311 |
| OR4K13 | RXFP1 | Q9HBX9 | 310 |
| OR4K13 | SPINT1 | O43278 | 308 |
| OR4K13 | CMKLR2 | P46091 | 302 |
| OR4K13 | POU3F1 | Q03052 | 290 |
| OR4K13 | PLCB1 | Q9NQ66 | 237 |
| OR4K13 | KCNQ2 | O43526 | 231 |
| OR4K13 | ABCB4 | P21439 | 219 |
| OR4K13 | PDPR | Q8NCN5 | 199 |
| OR4K13 | CEACAM4 | O75871 | 196 |
IntAct
0 interactions, top by confidence:
BioGRID (1): RPL32 (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: A0A096LPK9, A0A0X1KG70, A6NHA9, A6NMZ5, P0C604, P0C623, P0C645, P0DN82, P58180, P58182, Q15615, Q60881, Q6IF82, Q8IXE1, Q8N0Y3, Q8NGA8, Q8NGB4, Q8NGB6, Q8NGC2, Q8NGC3, Q8NGD0, Q8NGD1, Q8NGD2, Q8NGD5, Q8NGE8, Q8NGF4, Q8NGF8, Q8NGF9, Q8NGI4, Q8NGI6, Q8NGJ0, Q8NGJ1, Q8NGL6, Q8NGM1, Q8NGN0, Q8NGN8, Q8NGX5, Q8NH05, Q8NH42, Q8NH49
Diamond homologs: A0A096LPK9, A0A0X1KG70, A6NHA9, A6NMZ5, O60412, O76099, O95013, P0C604, P0C623, P0C645, P0DN82, P23270, P23275, P58173, P58180, P58182, Q15615, Q60878, Q60881, Q60888, Q6IEV9, Q6IEY1, Q6IF82, Q7TQQ0, Q8IXE1, Q8N0Y3, Q8N628, Q8NGA8, Q8NGB2, Q8NGB4, Q8NGB6, Q8NGB8, Q8NGB9, Q8NGC2, Q8NGC3, Q8NGC4, Q8NGC6, Q8NGD0, Q8NGD1, Q8NGD2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
54 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 52 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
278 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 14:20034492:A:AC | donor_gain | 0.6800 |
| 14:20034493:C:CC | donor_gain | 0.6800 |
| 14:20034614:CAG:C | donor_gain | 0.6700 |
| 14:20034616:G:C | donor_gain | 0.6300 |
| 14:20034493:CGTT:C | donor_gain | 0.6100 |
| 14:20034207:C:CT | acceptor_gain | 0.5900 |
| 14:20034727:T:TA | donor_gain | 0.5900 |
| 14:20034190:T:C | acceptor_gain | 0.5500 |
| 14:20034734:C:CT | donor_gain | 0.5400 |
| 14:20034583:A:C | donor_gain | 0.5300 |
| 14:20034210:A:T | acceptor_gain | 0.5000 |
| 14:20034754:T:A | donor_gain | 0.4900 |
| 14:20034251:C:CT | acceptor_gain | 0.4800 |
| 14:20034085:A:AC | donor_gain | 0.4700 |
| 14:20034086:C:CC | donor_gain | 0.4700 |
| 14:20034189:CT:C | acceptor_gain | 0.4700 |
| 14:20034190:TT:T | acceptor_gain | 0.4700 |
| 14:20034431:TCCCA:T | donor_gain | 0.4700 |
| 14:20034432:CCCAC:C | donor_gain | 0.4700 |
| 14:20034433:CCACC:C | donor_gain | 0.4700 |
| 14:20034434:CACCC:C | donor_gain | 0.4700 |
| 14:20034435:ACCCA:A | donor_gain | 0.4700 |
| 14:20034436:CCCAG:C | donor_gain | 0.4700 |
| 14:20034734:CCA:C | donor_gain | 0.4700 |
| 14:20034081:CCTAA:C | donor_gain | 0.4600 |
| 14:20034471:TCCCC:T | donor_gain | 0.4500 |
| 14:20034621:CAAGA:C | donor_gain | 0.4500 |
| 14:20033985:G:C | acceptor_gain | 0.4400 |
| 14:20034086:C:A | acceptor_gain | 0.4400 |
| 14:20034735:C:CT | donor_gain | 0.4400 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000031384 (14:20035081 G>A), RS1000490138 (14:20036391 C>T), RS1001180230 (14:20034548 T>C), RS1001342959 (14:20031821 T>A,C), RS1001729033 (14:20029061 A>C,G), RS1002334082 (14:20033319 G>C), RS1002404588 (14:20037988 T>C), RS1003128895 (14:20029025 C>A,T), RS1003147838 (14:20032399 A>G,T), RS1003180464 (14:20031989 G>A), RS1003813434 (14:20037081 A>G), RS1004138513 (14:20030129 G>A,T), RS1005101700 (14:20031701 T>G), RS1005152278 (14:20031417 G>A), RS1005729713 (14:20037970 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
3 total (human), top 3 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | increases expression, decreases methylation | 2 |
| bisphenol A | increases methylation, affects cotreatment | 1 |
| Fulvestrant | affects cotreatment, increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.